South San Francisco, CA 4/16/08—Fluidigm, which develops, manufactures and sells Integrated Fluidic Circuit systems (IFCs) for life science research, has filed for an IPO on the NASDAQ stock exchange. The number of shares to be offered and the price have not yet been determined. According to the filing, in 2007, Fluidigm’s revenues increased 19.9% to $7.7 million and operating loss declined from $21.7 million to $16.5 million. Sales to North America, Europe and Asia represented 54%, 17% and 29% of product revenues, respectively, last year. At the end of 2007, the company’s accumulated deficit was $133.8 million.